Screening to prevent osteoporotic fractures in Egypt: a position statement of the Egyptian Academy of Bone Health

[1] El Miedany Y(2023)Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study Arch Osteoporos 18 58-466

[2] El Gaafary M(2023)Incidence and geographic characteristics of the population with osteoporotic hip fracture in Egypt- by the Egyptian Academy of Bone Health Arch Osteoporos 18 115-9

[3] Gadallah N(2000)Deterioration in quality of life following hip fracture: a prospective study, Osteoporos. Int 11 460-2531

[4] Mahran S(2023)The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis Osteoporos Int 34 1-94

[5] Fathi N(2020)FRAX: re-adjust or re-think Arch Osteoporos 15 150-24

[6] Abu Zaid MH(2018)Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement JAMA 319 2521-791

[7] Tabra SAH(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 W65-undefined

[8] Hassan W(2000)Fracture intervention trial. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group J Clin Endocrinol Metab 85 4118-undefined

[9] Elwakil W(2021)Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases Egypt Rheumatol Rehabil 48 5-undefined

[10] El Miedany Y(2022)Operative secondary prevention of fragility fractures: national clinical standards for fracture liaison service in Egypt—an initiative by the Egyptian Academy of Bone Health Egypt Rheumatol Rehabil 11 49-undefined

[1] El Miedany Y(2023)Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study Arch Osteoporos 18 58-466

[2] El Gaafary M(2023)Incidence and geographic characteristics of the population with osteoporotic hip fracture in Egypt- by the Egyptian Academy of Bone Health Arch Osteoporos 18 115-9

[3] Gadallah N(2000)Deterioration in quality of life following hip fracture: a prospective study, Osteoporos. Int 11 460-2531

[4] Mahran S(2023)The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis Osteoporos Int 34 1-94

[5] Fathi N(2020)FRAX: re-adjust or re-think Arch Osteoporos 15 150-24

[6] Abu Zaid MH(2018)Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement JAMA 319 2521-791

[7] Tabra SAH(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 W65-undefined

[8] Hassan W(2000)Fracture intervention trial. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group J Clin Endocrinol Metab 85 4118-undefined

[9] Elwakil W(2021)Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases Egypt Rheumatol Rehabil 48 5-undefined

[10] El Miedany Y(2022)Operative secondary prevention of fragility fractures: national clinical standards for fracture liaison service in Egypt—an initiative by the Egyptian Academy of Bone Health Egypt Rheumatol Rehabil 11 49-undefined